Article Information
History
- June 8, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Gabriele Pagani1,†,
- Dario Bernacchia1,
- Federico Conti1,
- Andrea Giacomelli1,
- Rossana Rondanin6,
- Vittore Scolari5,
- Patrizia Boracchi4,
- Cecilia Eugenia Gandolfi2,†,
- Silvana Castaldi2,3,
- Elia Biganzoli4,* and
- Massimo Galli1,*
- 1Department of Clinical and Biomedical Sciences (DIBIC) “L. Sacco”, University of Milan, Italy
- 2Post graduate School in Public Health Dept Biomedical Sciences for Health, University of Milan, Italy
- 3Fondazione IRCCS Ca’ Granda Ospedale Maggiore policlinico di Milano, Italy
- 4Department of Clinical Sciences and Community Health & DSRC, University of Milan, Italy
- 5Institut Curie-PSL Research University, CNRS, Sorbonne Université, UMR3664, F-75005, Paris, France
- 6Medispa s.r.l.
- ↵†Corresponding Authors:
Gabriele Pagani, gabriele.pagani{at}unimi.it, ASST FBF-Sacco, Infectious Diseases Dep., III Division, Luigi Sacco Hospital, Via G.B. Grassi 74, 20157, Milan, Italy, Cecilia Eugenia Gandolfi, cecilia.gandolfi{at}unimi.it, Department of Biomedical Sciences for Health, University of Milan, Via C. Pascal 36, 20133, Milan, Italy
↵* Equally contributing Authors
Posted June 08, 2020.
Dynamics of the SARS-CoV-2 epidemic in the earliest-affected areas in Italy: Mass screening for SARS-CoV-2 serological positivity (SARS-2-SCREEN)
